Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease
10.1186/s13024-015-0067-y
Saved in:
Main Authors: | Baranyi M., Porceddu P.F., Gölöncsér F., Kulcsár S., Otrokocsi L., Kittel Á., Pinna A., Frau L., Huleatt P.B., Khoo M.-L., Chai C.L.L., Dunkel P., Mátyus P., Morelli M., Sperlágh B. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143623 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Clinical utility of neuroprotective agents in neurodegenerative diseases: Current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
by: Dunkel, P., et al.
Published: (2014) -
Synthesis of propargylamine mycophenolate analogues and their selective cytotoxic activity towards neuroblastoma SH-SY5Y cell line
by: Patamawadee Silalai, et al.
Published: (2022) -
Concise, efficient and practical assembly of bromo-5,6-dimethoxyindole building blocks
by: Huleatt, P.B., et al.
Published: (2014) -
Constructing homo- And hetero-metallic molecular topologies using pyridylcarboxylates as spacers: Preparation of a half-ring complex with active coordination sites
by: Teo, P., et al.
Published: (2014) -
A systems approach towards the stoichiometry-controlled hetero-assembly of nanoparticles
by: Wang, Y., et al.
Published: (2014)